Do SARMs Cause Hair Loss?

Member Access Required

Already a member? Sign In

Timeline

00:00

The introduction frames SARMs as a popular alternative for men worried about steroid stigma and hair loss. Street interviews, online claims, and patient feedback are compared to show mixed real world experiences.

04:09

The conversation lists common SARMs and explains why many users add hair focused medications and shampoos. A strict educational disclaimer is repeated, avoiding regimen doses while describing what people actually combine.

06:44

Mechanistic theories include low follicle receptor affinity and possible competitive inhibition against DHT. Another theme is rebound shedding after stopping SARMs, where receptor regulation may amplify DHT effects.

11:44

DHT blockers are outlined with finasteride and dutasteride, including indications and PSA masking concerns. The segment emphasizes tradeoffs, because blocking DHT may alter mood, libido, and brain driven confidence.

16:46

The ending promotes individualized monitoring, using labs and physician oversight to avoid hidden harms. A trial is cited suggesting muscle gains can still occur with DHT blockade, but polypharmacy remains risky.

Video Summary

The episode opens with frequent questions about SARMs and unexpected hair shedding among young men. Many people believe selective androgen receptor modulators can build muscle while sparing hair follicles. The doctor describes street interviews, online research, and feedback from long term clinic patients. Commonly discussed compounds include ostarine, LGD-4033, and S4, often called andarine. He notes that some users stack other agents, chasing hair protection more than overall health. A clear disclaimer is given that the discussion is educational and not a dosing recommendation. The central question becomes whether any SARM is truly selective at the hair follicle receptor.

Mechanisms are framed as complicated and still poorly understood in real clinical science. One idea presented is competitive inhibition at the DHT hair follicle receptor, possibly neutralizing DHT. Another repeated anecdote is that shedding can flare after stopping SARMs, with receptor regulation shifts. Genetics is emphasized as a major variable, meaning results differ widely from person to person. The conversation then turns to DHT blocking agents that many users add to hedge against balding. Finasteride is described as a five alpha reductase inhibitor that blocks DHT, while dutasteride is stronger. These medicines are linked to approved indications like benign prostatic hyperplasia and male pattern balding. Dutasteride is also said to lower PSA readings, creating a new baseline that could mask prostate disease.

The doctor states that DHT blockers can slow hair loss, but the real question is the cost. He highlights post finasteride syndrome concerns, including low testosterone symptoms, depression, and anxiety. Sex drive changes are discussed, because DHT activity in the brain is tied to confidence and well being. A cited randomized trial is mentioned where testosterone with dutasteride still increased fat free mass. Even with that muscle data, the broader message warns against polypharmacy and chasing cosmetic fixes. He urges proper history, physical examination, and baseline laboratory monitoring before any intervention. Suggested labs include total and free testosterone, DHT, ultrasensitive estradiol, prolactin, thyroid panels, and PSA. The closing theme is that balancing hormones can be done, yet it is labor intensive and individualized.

Drug Callouts

Finasteride

Finasteride is a five alpha reductase inhibitor that reduces conversion of testosterone to DHT. The transcript discusses it as a common add on used to slow male pattern hair loss.

Dutasteride

Dutasteride is a five alpha reductase inhibitor that blocks both type one and type two enzymes. The discussion warns it can lower PSA measurements and potentially mask prostate screening changes.

Minoxidil

Minoxidil is a topical vasodilator medicine used to stimulate hair growth in androgenetic alopecia. It is mentioned as one of several products users add when stacking SARMs for hair protection.

Ketoconazole

Ketoconazole is an antifungal medication often used in shampoos for scalp conditions and dandruff. The transcript lists ketoconazole shampoo as another tool commonly combined with hair loss routines.

Azelaic acid

Azelaic acid is a topical medication used for inflammatory skin conditions, including acne and rosacea. It is mentioned as a topical option people sometimes include alongside other hair focused agents.

Condition Callouts

Androgenetic alopecia

Androgenetic alopecia is a hereditary pattern of hair follicle miniaturization driven partly by DHT. The transcript links most hair loss worries to genetics and DHT signaling at the follicle receptor.

Benign prostatic hyperplasia

Benign prostatic hyperplasia is noncancerous enlargement of the prostate that can worsen urinary flow. Finasteride and dutasteride are referenced as medicines with established indications for BPH treatment.

Prostate cancer

Prostate cancer is malignant growth of prostate cells that may be detected through PSA screening trends. The transcript warns that dutasteride can lower PSA and potentially obscure a rising cancer signal.

Depression

Depression is a mood disorder marked by persistent low mood, reduced interest, and impaired functioning. The transcript mentions depression as a possible severe outcome reported with finasteride exposure.

Anxiety

Anxiety is a condition of excessive worry and physiologic arousal that can impair daily functioning. Anxiety is named alongside depression and rare suicides when discussing finasteride related concerns.

Post-finasteride syndrome

Post-finasteride syndrome is a term used for persistent sexual and neuropsychiatric symptoms after finasteride. The transcript raises this syndrome as a major reason to question hair saving strategies at any cost.

Key Takeaways

SARMs are widely discussed as muscle builders, yet hair outcomes vary by genetics and dose.
People often stack DHT blockers and topicals, which adds complexity and medical tradeoffs.
Finasteride and dutasteride may slow hair loss, but mood and libido effects are emphasized.
Dutasteride can lower PSA readings, so prostate monitoring needs careful interpretation.
Close medical monitoring with targeted labs is urged instead of uncontrolled polypharmacy.